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Abstract 
Biomaterials hold promise for diverse therapeutic applications in the central nervous system 
(CNS). Little is known about molecular factors that determine CNS foreign body responses (FBRs) in 
vivo, or about how such responses influence biomaterial function. Here, we probed these factors using a 
platform of injectable hydrogels readily modified to present interfaces with different representative 
physiochemical properties to host cells. We show that biomaterial FBRs mimic specialized multicellular 
CNS wound responses not present in peripheral tissues, which serve to isolate damaged neural tissue 
and restore barrier functions. Moreover, we found that the nature and intensity of CNS FBRs are 
determined by definable properties. For example, cationic, anionic or nonionic interfaces with CNS cells 
elicit quantifiably different levels of stromal cell infiltration, inflammation, neural damage and amyloid 
production. The nature and intensity of FBRs significantly influenced hydrogel resorption and molecular 
delivery functions. These results characterize specific molecular mechanisms that drive FBRs in the 
CNS and have important implications for developing effective biomaterials for CNS applications.   
 
Introduction 
Biomaterials are under widespread investigation for experimental and therapeutic applications in 
the central nervous system (CNS) [1]. Biomaterials with specialized properties have been incorporated in 
implantable neuroprostheses that are used clinically for recording neuronal activity and stimulating 
neural circuits in the CNS [2, 3]. In addition, injectable biomaterial hydrogels are used extensively as 
experimental tools to provide local delivery of growth factors for example to attract injured and 
regenerating axons to grow across CNS lesions [4, 5] as well as to afford molecular and physical support 
to co-suspended neural progenitor cells (NPC) to improve survival and modulate differentiation upon 
grafting into the CNS [6-8].  
While various classes of biomaterials may be used for applications in the CNS, synthetic or 
naturally derived polymers are the predominate choice for directly interfacing with host CNS tissue and 
cells [9, 10]. For neuroprostheses, diverse classes of polymers are used as the outer substrates or 
coatings for metal electrodes intended to improve device insertion and long term performance in vivo 
[10, 11]. In addition, new devices based on electrically conducting polymers are also being developed 
[12]. For hydrogels, considerable progress has been made in synthesizing new polymers with tunable 
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physiochemical properties to achieve spatial and temporal control of molecular release or provide unique 
support to co-suspended cells [13-16].   
Despite innovations in the many engineering and design aspects of biomaterials that are used for 
CNS applications, little is known about factors that determine the CNS foreign body response (FBR) in 
vivo to these materials, or how such responses influence function. Assessments of cytotoxicity and 
biocompatibility of biomaterial interfaces with host cells, or biomaterial functions such as molecular 
release kinetics are often evaluated primarily in vitro or through subcutaneous implantation in vivo [17, 
18]. However, in vitro observations and the FBR associated with subcutaneously implanted biomaterials 
need not predict in vivo performance in the CNS, where there is a highly specialized and unique 
multicellular wound response that serves to isolate damaged tissue and restore barrier functions.  
Substantial advances have been made in understanding the CNS wound response, which can 
inform the study of CNS FBRs. The CNS wound response is a biologically conserved process whereby 
perturbations of CNS tissue lead to dynamic multi-cellular interactions that efficiently isolate regions 
perceived as damaged, infected or diseased to protect adjacent viable neural tissue and permit recruited 
inflammation to resolve potentially noxious elements [5, 19-21]. This multicellular CNS wound response 
generates tissue lesions characterized by distinct non-neural and neural cellular compartments in which 
non-neural lesion cores with stromal and inflammatory cells are segregated from adjacent spared and 
viable neural tissue by an astroglial scar or limitans border [22]. The cellular responses to materials 
perceived as foreign are likely to be related to this multicellular natural wound response [23], but the 
study of CNS FBRs to biomaterials in vivo has not kept pace with recent advances made in the cell 
biology of CNS injury. There is a need to better understand: (i) key cellular interactions of CNS FBRs to 
biomaterials, (ii) biomaterial properties that influence the severity of CNS FBRs, and (iii) the extent to 
which CNS FBRs influence biomaterial function in vivo. Here, we evaluated these parameters by 
comparing multiple synthetic and naturally derived hydrogel-based biomaterials.  
As a platform to determine the effects of specific molecular features on biomaterial-evoked FBRs, 
we used synthetic, diblock copolypeptide hydrogels (DCH), which can be readily modified to present 
interfaces with different representative physiochemical properties to host cells whilst retaining consistent 
polymer chain lengths and mechanical properties [8, 24, 25]. These shear-thinning, physical hydrogels 
can be administered to focal CNS regions in a minimally invasive manner by infusion through narrow 
cannulae ensuring that minimal tissue damage is induced by the implantation of the biomaterial that 
could otherwise confound the CNS FBR evaluation of the host-biomaterial interface [24-26]. Moreover, 
because these hydrogels can be prepared to exhibit the same mechanical stiffness as CNS tissue (ca. 
100-400 Pa) [25], they can be fixed and processed in situ and retain their intimate contact with 
immediately adjacent host cells so that directly contiguous biomaterial-host interfaces can be examined 
and quantified in detail. This type of analysis is not possible with rigid, mechanically stiff or hydrophobic 
materials and coated electrodes that must be removed before tissue sectioning, because this removal 
invariably also disrupts the immediate material-cellular interfaces, which cannot then be evaluated.   
We benchmarked our findings using DCH that present physiochemically defined interfaces 
against various commonly used, commercially available and previously CNS tested hydrogel 
formulations and compared FBRs with naturally evoked CNS wound responses modeled using 
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chemically induced ischemic strokes that were equivalent in size to the hydrogel depots. We show that 
the CNS FBR to biomaterial interfaces is a multicellular process that mimics conserved elements of CNS 
wound healing and exists on a definable severity spectrum characterized by the presence or absence of 
specific different types of non-neural cells. Furthermore, the nature and intensity of CNS FBRs are 
determined by definable material properties and elicits quantifiable differences in relevant functions 
including hydrogel resorption and molecular delivery.  
 
Results 
Hydrogel-evoked FBRs vary and mimic CNS wound responses 
We first compared cellular profiles of mild or severe CNS wound responses with FBRs of two 
structurally similar, synthetic, diblock copolypeptide hydrogels (DCH) that present either strongly cationic 
(DCHK) or nonionic (DCHMO) interfaces to host cells (Fig. 1a). Lysine-based DCHK and methionine-
sulfoxide based DCHMO are both well tolerated in vivo [8, 25], but exhibit noticeably different FBRs. For 
comparison, mild or severe CNS wound responses were induced by injection of innocuous phosphate 
buffered saline (PBS), or N5-(1-iminoethyl)-l-ornithine (L-NIO) solution that creates a small focal 
ischemic stroke [27]. PBS, DCHMO, DCHK, or L-NIO were injected into caudate putamen (CP) of mouse 
forebrain (Fig. 1b). The CP site is easily accessible, allows for consistent and reproducible hydrogel 
injections that are well tolerated by the mice, and is composed of neural tissue with neuronal cell bodies, 
myelinated axon bundles and a diversity of neuroglial making it an advantageous location for 
standardized CNS FBR assessments [25]. Hydrogel FBRs and wound responses were characterized 
with immunohistochemistry for CD13 to identify non-neural cells including stromal and peripheral myeloid 
lineage cells recruited as part of the sterile inflammatory response to tissue damage [28]. CD13 
positively identifies the full temporal range of non-neural tissue remodeling from acute inflammation 
through to chronic fibrotic lesion formation. In the healthy uninjured mouse brain, CD13 is expressed by 
pericytes and perivascular fibroblasts along cerebrovasculature and meningeal fibroblasts [29] 
(Supplementary Fig. 1a-d). CD13 is not expressed by neuroglia or neurons. Staining for glial fibrillary 
acidic protein (GFAP) identified reactive and scar-border forming astrocytes [30], P2RY12 identified CNS 
microglia and NeuN identified viable neurons.   
At one week after injections, (i) PBS infusions were detectible as small areas of GFAP-positive 
reactive astrocytes; (ii) nonionic DCHMO and cationic DCHK, exhibited similarly sized deposits; and (iii) L-
NIO created sharply demarcated areas of infarcted tissue equivalent in size to hydrogel deposits (Fig. 
1c). DCHMO and DCHK deposits and L-NIO infarcts were all surrounded by similarly appearing borders of 
GFAP-positive astrocytes that clearly separated neural tissue containing NeuN-positive neurons from 
non-neural cores with CD13-positive cells and hydrogels (Fig. 1c,d). CD13-positive cells were not 
elevated at the centers of PBS injections or at interfaces between DCHMO and host. By contrast, a dense 
CD13-positive cell capsule, 164±19µm in thickness, had completely surrounded and infiltrated the 
margins of DCHK deposits, while CD13-positive cells had entirely filled L-NIO infarcts (Fig. 1c,d). Similar 
CD13-positive cell accumulation and non-neural/neural cell compartmentalization was observed one 
week after forebrain stab injury through cerebral cortex (Supplementary Fig.1e). Quantification showed 
that total CD13 levels across the different compartments of infusion sites and adjacent neural tissue 
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were similar after PBS and DCHMO and were significantly higher after DCHK and L-NIO (Fig. 1e; 
Supplementary Fig. 2). Notably, the significant increases in CD13 levels after DCHK and L-NIO were 
confined to central non-neural tissue compartments of hydrogel plus infiltrating cells, and there was no 
significant difference in CD13 levels in surrounding neural tissue (defined as tissue containing neuroglia 
and neurons) adjacent to PBS, DCHMO, DCHK or L-NIO (Fig. 1f). Moreover, although GFAP levels were 
significantly lower adjacent to PBS injections, there was no significant difference in GFAP levels adjacent 
to DCHMO, DCHK or L-NIO (Fig. 1g).  
 
 
Fig. 1 | Hydrogel-evoked FBRs vary and exhibit cellular features of CNS wound response. a. Schematic and chemical 
structures of synthetic hydrogels used as tools to study CNS FBR. b. Experimental model of in vivo injections into caudate 
putamen (CP) of mouse forebrain. c,d. Survey and detail images of stromal and inflammatory cells (CD13), astrocytes (GFAP) 
and neurons (NeuN) at one week after injections of PBS, hydrogels or L-NIO-induced stroke. e-g. Quantification of total 
immunohistochemical staining. e. Total CD13 in CP. NS not significant, ***P < 0.0001 versus PBS injection, one-way ANOVA with 
Bonferroni. f. Total CD13 in either non-neural or neural tissue compartments. NS or ***P < 0.0001 versus PBS injection, two-way 
ANOVA with Bonferroni. g. Total GFAP in CP. NS or ***P < 0.0001 versus DCHMO, one-way ANOVA with Bonferroni. Graphs are 
mean ± s.e.m with individual data points showing n mice per group. AU arbitrary units, G hydrogel, IC internal capsule.  (one 
column width figure) 
 
These findings show that DCH-based hydrogels presenting precisely defined cationic (DCHK) or 
nonionic (DCHMO) interfaces to host cells exhibit FBRs whose cellular profiles and compartmentalization 
mimic those of normal CNS wound responses, and that the FBR to different hydrogels can vary 
significantly. These findings also suggested that hydrogel surface chemistry and properties such as 
charge may influence hydrogel FBR.   
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FBRs vary with definable hydrogel properties 
We next characterized FBRs to various cationic, anionic and nonionic hydrogels. We 
manufactured DCH that presented different polar side chains to interface with host cells but maintained 
consistent poly(L-leucine) hydrophobic blocks [8, 24, 25] (Supplementary Fig. 3a,b). We compared these 
DCH with various commercially available formulations commonly used in CNS applications: 
methylcellulose (MC) [31], a hyaluronic acid/methylcellulose blend (HAMC) [32], and a chitosan/β-
glycerophosphate (CHIT) system [33]. Hydrogels with comparable mechanical properties (see [8, 25, 34] 
and Supplementary Fig.3c) were injected into mouse forebrain (Fig. 1b), and cellular FBR profiles were 
first characterized with immunohistochemistry for CD13, GFAP and NeuN (Fig. 2; Supplementary Figs. 
2,4,5).   
 
Fig. 2 | Hydrogels that present cationic interfaces with host cells exhibit increased FBR severity. a,b. Survey images of 
stromal and inflammatory cells (CD13), astrocytes (GFAP) and all cell nuclei (DAPI) at one week after injection of nonionic and 
anionic (a), and cationic (b) hydrogels. c-e. Quantification of total immunohistochemical staining. c,d. Total CD13 in non-neural 
(c) and neural (d) tissue compartments. NS not significant, ***P < 0.0001, two-way ANOVA with Bonferroni. e. Total GFAP in CP, 
NS, one-way ANOVA with Bonferroni. Graphs are mean ± s.e.m with individual data points showing n mice per group.  (one 
column width figure) 
 
Qualitative and quantitative examination showed that nonionic MC, like nonionic DCHMO, 
exhibited barely detectable levels of CD13-positive cells at interfaces with host tissue (Fig. 2a,c; 
Supplementary Fig. 4a). Moreover, anionic hydrogels HAMC as well as glutamate (E) inclusive DCHE 
and DCHMOE15 also exhibited barely detectable levels of CD13-positive cells at host interfaces (Fig. 2a,c; 
Supplementary Fig. 4a). However, in striking contrast, cationic hydrogels, DCHK, DCHMM, DCHMOK15, 
DCHMOK10 and CHIT all exhibited large rims of CD13-positive cells infiltrating into deposits around their 
entire host interface and had significantly higher CD13-levels in central non-neural compartments, which 
did not differ in magnitude across different cationic hydrogels (Fig. 2b,c; Supplementary Fig. 4b). To 
directly probe the relationship between cationic charge and FBR, we incorporated variable amounts of 
lysine (K) into nonionic DCHMO as a statistical copolymer [8] (Supplementary Fig. 3b). DCHMOK15 and 
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DCHMOK10 both exhibited outer rims of infiltrating CD13 cells similar to DCHK, but with more cells 
infiltrating into the deposit center, suggesting that small amounts of dispersed cationic charge attracted 
CD13 cells, whereas dense charge in DCHK prevented these same cells from distributing throughout the 
bulk of the material. In addition, we generated cationic, methyl-sulfonium-based DCHMM (Supplementary 
Fig.3b) [8], which also exhibited a rim of infiltrating CD13 cells similar to DCHK, but in addition exhibited 
many DAPI-positive but CD13-negative cells that formed a distinct and separated layer of cells that 
directly interfaced with the hydrogel deposit surface (Fig. 2b). Similar CD13-negative cells at the material 
interface were not obviously present in other DCH, but were present within CHIT deposits (Fig. 2b), 
suggesting a distinct cellular infiltrate requiring further characterization as conducted below. 
These findings show that hydrogel FBRs vary with definable hydrogel properties and implicate 
cationic charge presented at material interfaces with host tissue as a major factor determining FBR 
severity. Remarkably, despite significantly elevated CD13 in the non-neural compartments of cationic 
hydrogels (Fig. 2a-c), there was no significant difference in either CD13 (Fig. 2d; Supplementary Fig. 5) 
or GFAP (Fig. 2e) levels, and no detectable qualitative difference in NeuN-positive neuron density 
(Supplementary Fig. 5), in the neural tissue adjacent to either cationic, nonionic or anionic hydrogels, 
suggesting that neural tissue beyond the interface between hydrogel and host was not substantively 
differentially impacted. The unexpected finding that GFAP levels were indistinguishable in neural tissue 
adjacent to hydrogels that evoked markedly different FBR at host interfaces indicates that GFAP staining 
is not a sensitive or sufficient marker with which to evaluate and differentiate FBRs.   
 
Hydrogel FBRs differ in inflammatory cell recruitment/persistence 
To discriminate among diverse innate-immune inflammatory cells involved in hydrogel FBRs, we 
used immunohistochemistry for: (i) CD45 to identify leukocytes and reactive CNS microglia [35]; (ii) Iba-1 
to identify blood-borne monocytes/macrophages and CNS microglia [35]; (iii) P2RY12 to identify only 
microglia [20, 36, 37]; (iv) Ly6B2 to identify neutrophils [21]; and (v) CD13 to identify myeloid lineage 
peripheral inflammatory cells such as monocytes and macrophages or fibroblast lineage cells (Fig. 3) 
[28]. We examined combinations of these markers at one week after hydrogel injections (Fig. 1b).  
For all hydrogels, the neural tissue immediately adjacent to deposits contained reactive, CNS-
derived microglia that were Iba-1-, CD45- and P2RY12-positive and CD13-negative that intermingled 
with astrocytes and neurons, remained within the neural tissue compartment and did not detectably 
infiltrate into any hydrogel (Figs. 3a,b; Supplementary Fig.6a). P2RY12 expression was reduced in 
reactive microglia that dispersed directly within forming astroglia borders. Immediately abutting these 
microglia, hydrogel deposits exhibited variable intensities of inflammatory cell infiltrates that were CD45- 
and CD13-positive, and P2RY12-negative, and were peripherally-derived myeloid lineage leukocytes 
and not CNS microglia (Fig. 3a,b, Supplementary Fig. 6a,b). A comparable segregation of blood-borne 
inflammatory cells into a non-neural tissue compartment away from neural tissue was also observed for 
the L-NIO stroke lesion (Supplementary Fig. 6c). 
Different hydrogels exhibited remarkable variation in both the intensity and cellular phenotype of 
the blood-borne inflammatory response that they attracted. Nonionic DCHMO attracted only rare 
infiltrating CD45-positive leukocytes at interfaces with host tissue, and these were macrophage lineage  
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Fig. 3 | Different hydrogels attract inflammatory responses that differ in intensity and cellular phenotype. a. Detail images 
of differences in inflammatory cell recruitment one week after injection of DCHMO, DCHK, DCHMM hydrogels (G). b. Detail images 
showing that CNS-derived P2RY12 positive microglia do not migrate into non-neural tissue compartments in spite of different 
FBRs evoked by DCHMO, DCHK, DCHMM. c. Detail images of hydrogel-tissue interface showing the escalating recruitment and 
persistence of Ly6B2-positive neutrophils at cationic hydrogel surfaces at one week after injection. d. Quantification of total Ly6B2 
staining for hydrogels one week after injection. NS not significant and **P < 0.002 for hydrogels versus DCHMM, one-way ANOVA 
with Bonferroni. e. Table summarizing the combination of antibodies used to identify different inflammatory cell types. Graphs 
show mean ± s.e.m with individual data points showing n mice per group.   (one column width figure) 
 
(Iba1-positive and CD13-positive) (Fig. 2a,3a,b; Supplementary Fig. 6a). In contrast, cationic DCHK and 
DCHMM both attracted thick rims of infiltrating macrophage-lineage cells (CD45-positive, Iba1-positive 
and CD13-positive) along their entire host interfaces (Fig. 2b,3a,b; Supplementary Figs. 4,6a). 
Immunohistochemical staining also revealed that the thick layers of DAPI-positive and CD13-negative 
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cells infiltrating into DCHMM and CHIT (Fig. 2b) were leukocytes (CD45-positive), but were not 
macrophage lineage (Iba1-negative) (Fig. 3a), and instead were highly phagocytic and cytotoxic Ly6B2-
positive neutrophils (Fig. 3b,c; Supplementary Fig. 6b). In striking contrast, nonionic DCHMO and weakly 
cationic DCHMOK10 or anionic DCHMOE15, contained no detectable Ly6B2-positive neutrophils, while 
strongly cationic DCHK attracted a few of these cells (Fig. 3c,d; Supplementary Fig. 6a).   
To test whether inflammatory response intensity correlated directly with strength of cationic 
charge at hydrogel surfaces, we measured zeta potentials of DCH hydrophilic polymer chains. DCHK, 
containing homopolymers of lysine, had a significantly greater positive charge at physiological pH than 
DCHMM (containing statistical copolymers with 10% uncharged alanine) due to a higher total number of 
charged side chain groups along each hydrophilic chain (Supplementary Fig. 6d). However, DCHK had 
significantly lower levels of neutrophils and equivalent levels of macrophages compared to DCHMM (Fig. 
3d). Nonionic DCHMO had no detectable charge, no infiltration of neutrophils and only rare macrophages 
(Fig. 3a,b,c; Supplementary Fig. 6d).  
Persistence of peripheral inflammatory cells at hydrogel deposits was evaluated at three weeks 
after injection (Supplementary Fig. 7a,b). Notably, while Ly6B2-positive neutrophils were mostly resolved 
at CHIT deposits by 3 weeks, thick rims of these acute inflammatory cells were sustained at DCHMM 
deposits with a distribution that was not obviously different to that at one week. DCHMM deposits also 
remained largely un-resorbed at 3 weeks whereas CHIT injections were completely infiltrated by cells at 
this time point (Supplementary Fig. 7c).  
These findings show that the intensity and duration of the inflammatory cell components of CNS 
FBRs varied markedly in response to deposits of different hydrogels and that cationic charge at material-
host interfaces is an important factor in attracting blood-borne phagocytic leukocytes. Nevertheless, 
charge magnitude alone does not determine the nature or distribution of phagocytes attracted.  
 
Hydrogel FBRs involve stromal cells and fibrosis 
To characterize fibrosis associated with hydrogel FBRs, we compared a representative hydrogel 
with limited detectable CD13 levels (DCHMO) to a representative hydrogel with a pronounced but focal 
rim of CD13 cells (DCHK) using immunohistochemistry for cell surface and extracellular matrix 
molecules, collagen-1a1, fibronectin, laminin, and galectin-3 with staining for CD13 at various times after 
hydrogel injections (Figs. 1b,4a-e). Collagen-1a1, fibronectin and laminin demarcate stromal cells [38] , 
whereas galectin-3 can demarcate multiple cell types including stromal and inflammatory cells [39-41]. In 
uninjected normal neural tissue, (i) CD13 stained stromal cells along blood vessels and at the meninges, 
(ii) collagen-1a1 and laminin lightly decorated cell surfaces along blood vessels and around neurons, (iii) 
fibronectin was present at large vessels and at the meninges, and (iv) galectin-3 was essentially 
undetectable [42] (Supplementary Fig. 8a).  
At one week after injection, tissue adjacent at interfaces with non-ionic DCHMO exhibited staining 
for collagen-1a1 and laminin only along blood vessels in a manner similar to normal neural tissue, 
whereas fibronectin and galectin-3 were moderately elevated in narrow rims along host-gel interfaces 
(Fig. 4a,c-e). In contrast, the thick capsule of CD13-positive cells circumscribing cationic DCHK exhibited 
significantly greater levels of collagen-1a1, laminin, fibronectin and galectin-3 (Figs. 4b,c). Around DCHK, 
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galectin-3 was robustly expressed by essentially all CD13-positive cells, whereas collagen-1a1, laminin 
and fibronectin demarcated subsets of stromal cells in outer margins (Fig. 4b) that interfaced directly with 
the forming astrocyte limitans border. An interior layer of CD13- and galectin-3-positive but collagen-1a1, 
fibronectin and laminin-negative cells, likely peripheral inflammatory cells, interacted directly with the 
DCHK surface (Fig. 4b). This inflammatory and fibrotic cell stratification around DCHK is reminiscent of 
the cellular organization in CNS abscesses and traumatic injury lesions [40, 43]. CD13- and galectin-3-
positive cells persisted chronically in the non-neural tissue compartment of resorbed DCHK for at least 6 
weeks (Fig. 4f). Interestingly, the GFAP-positive astrocyte limitans border that formed the direct host 
interface with non-ionic DCHMO also extensively expressed galectin-3 and this expression persisted 
chronically for at least 6 weeks (Fig. 4d,e; Supplementary Fig. 8b).  
These findings show that DCHMO evokes minimal levels of fibrosis, whereas cationic DCHK 
evokes a stronger fibrotic FBR with elevated levels of multiple matrix molecules at the interface with 
preserved neural tissue. Additionally, we identified a possible conserved function for galectin-3 in 
isolating foreign bodies from parenchymal neural tissue regardless of the severity of the FBR, with its 
expression occurring rapidly following hydrogel injection and present only in cells forming the material-
tissue interface, regardless of cell type (inflammatory cells, stromal cells or astrocytes). Galectin-3 is 
known to be associated with fibrosis and wound healing in various tissue injuries including kidney, liver 
and heart [44] and is significantly upregulated in macrophages/microglia and reactive astrocytes after 
various traumatic CNS injuries [42, 45-47]. Here we identify galectin-3 to also be an important 
constituent of CNS FBRs to materials.  
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Fig. 4 | Hydrogels evoke fibrotic responses at the material-tissue interface that can involve stromal or astroglial cells. 
a,b. Detail images of stromal-associated markers, collagen 1a1 (Col1a1), fibronectin, laminin, and galectin-3 (Gal-3) and their 
relationship to non-neural CD13 positive cells at the tissue interface of DCHMO (a) and DCHK (b) at one week after injection 
(hydrogels, G). Colocalization of markers with CD13-positive cells is seen as white staining. c. Quantification of total Col1a1 and 
Gal-3 staining at one week after hydrogel injection. ***P < 0.0001 for DCHMO versus DCHK for the two stromal markers, two-way 
ANOVA with Bonferroni. Graphs show mean ± s.e.m with individual data points showing n mice per group. d. Detail image showing 
that adjacent to DCHMO, Gal-3 colocalizes with a narrow band of GFAP positive astrocytes that border the gel at 1 week. Gal-3 
and GFAP colocalization is seen as white staining. e,f. Detail images showing the temporal evolution of Gal-3 expression at the 
interface of DCHMO (e) and DCHK (f) at acute (48 hours, 48h), subacute (1 week,1wk) and chronic (6 weeks, 6wk) timepoints after 
injection. Gal-3 and GFAP colocalization is seen as yellow staining. Gal-3 and CD13 colocalization is seen as white staining.  (one 
column width figure)    
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Tissue damage drives FBR and causes acute amyloid formation 
We next looked for associations between FBR, inflammation, fibrosis and host tissue loss, and 
for other potential molecular features shared across FBR and CNS wound response. To do so, we first 
used mice expressing reporter protein transgenically-targeted to host astrocytes via Aldh1l1-Cre-ERT2 
and evaluated host neural tissue damage and changes in various molecular markers, including 
accumulation of amyloid precursor protein (APP), a robust marker of axonal injury [48] and one of its 
breakdown products, beta-amyloid (Aβ) [49]. We compared representative hydrogels displaying minimal 
or pronounced FBRs with the CNS wound response to L-NIO stroke lesions at various time points.   
At 48 hours after injection, DCHMO exhibited a minimal zone of host neural tissue loss averaging 
only 25µm, the equivalent of one or two cells in thickness, whereas DCHK exhibited a significantly 
greater, but still relatively small zone of host neural tissue loss of about 150µm in thickness, as 
evidenced by: (i) astrocyte and neuron loss but persistence of vasculature, (ii) presence and 
phagocytosis of reporter protein debris, (iii) extravasation of blood borne fibronectin [50], (iv) up-
regulation of CD13 expression along thin PECAM-1-positive blood vessels within the damaged tissue 
zone and (v) infiltration of blood-borne phagocytic leukocytes (Fig. 5a,b; Supplementary Fig. 9a-e).  
Further characterization of the extent of axonal injury was provided by amyloid precursor protein 
(APP) staining. APP is low or undetectable by immunohistochemistry in healthy CNS tissue, but 
increases markedly after axonal injury [48, 51]. After 48 hours, DCHMO displayed only small amounts of 
APP accumulation at the hydrogel-host interface (Fig. 5c). In contrast, APP was present throughout the 
narrow zone of neural tissue damage induced by DCHK and APP accumulation was prominent in 
damaged axon bundles close to DCHK deposits in a manner comparable with L-NIO stroke lesions (Fig. 
5c). By one week, APP staining had decreased substantially and was detectable only at the interface of 
neural to non-neural tissue, and APP had returned to baseline at six weeks across all conditions (Fig. 
5c).  
The formation of beta-amyloid (Aβ) via cleavage of APP by β- and γ-secretase enzymes is 
increasingly recognized as a normal occurrence during CNS wound responses [52, 53]. We evaluated 
the progression of APP to Aβ (Fig. 5d). At 48 hours, Aβ was sparse at the hydrogel-tissue interface for 
both DCHMO and DCHK, whereas L-NIO stroke lesions already showed clear Aβ accumulation at the 
borders of infarcted and spared neural tissue (Fig.5d). By one week, Aβ was barely detectable around 
DCHMO and was comparable to PBS injections where Aβ was constrained to the track of tissue disrupted 
by the injection pipette (Supplementary Fig. 10a,b). At one week after DCHK, DCHMM injections and L-
NIO stroke lesions, Aβ accumulation was most prominent within the layers of CD13-positive 
inflammatory cells that infiltrated areas of neural tissue damage (Fig. 5d,e). In addition, in all conditions, 
there was prominent colocalization of Aβ within Iba-1-positive reactive microglia in adjacent spared 
neural tissue, suggesting phagocytosis by these cells as well (Fig. 5e, Supplementary Fig. 10c). 
Quantification confirmed significantly higher levels of Aβ at one week for DCHK and DCHMM compared to 
DCHMO (Fig. 5e,f). Increased neutrophil accumulation and persistence in DCHMM compared to DCHK 
(Fig. 3c,d) was not associated with any increase in Aβ formation (Fig. 5e,f) suggesting that Aβ is formed 
as a result of acute neural tissue injury and not by ongoing chronic inflammation. At 6 weeks, Aβ levels 
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had reduced markedly and were evident only within the persistent non-neural tissue lesions for DCHK 
and L-NIO stroke (Fig. 5d).  
 
Fig. 5 | Hydrogel FBR severity is determined by the extent of acute neural tissue damage at the material interface, which 
is associated with axonal damage, APP accumulation and amyloid formation. a. Detail images of the material-tissue 
interface for DCHMO and DCHK at 48 hours after injection. ALDH1L1-tdT reporter and GFAP identify host astrocytes and the loss 
of these cells demarcates regions of host tissue damage. b. Quantification of radial thickness of tissue damage around DCHMO 
and DCHK. ***P < 0.0001 Welch’s (unequal variance) t-test. c,d. Detail images for DCHMO, DCHK, and L-NIO-induced stroke at 
acute (48 hours, 48h), sub-acute (1 week, 1wk) and chronic (6 weeks, 6wk) timepoints after injection, comparing staining for 
amyloid precursor protein (APP) (c) or amyloid-beta (Aβ) (d) with GFAP and CD13. e. Images show Aβ, Iba-1 and CD13 at the 
interface of DCHMO, DCHK and DCHMM with host tissue at one week after injection. f. Quantification of Aβ at one week after 
DCHMO, DCHK and DCHMM. NS or *P < 0.02 for hydrogels versus DCHK, one-way ANOVA with Bonferroni. Graphs shows 
mean ± s.e.m with individual data points showing n mice per group. G hydrogels, ax axons. (one column width figure)  
 
These finds show that the inflammatory and fibrotic FBRs evoked by cationic hydrogels were 
driven by narrow but measurable zones of host neural tissue damage occurring along hydrogel-host 
interfaces soon after injection and that this was essentially absent with the nonionic DCHMO. These 
findings also show that APP accumulation and Aβ formation around hydrogel deposits occurred as a 
result of damage to neural tissue and axonal injury. These observations are consistent with growing 
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evidence that APP accumulation and subsequent Aβ formation are part of a conserved innate wound 
and foreign body response. While the specific functions of Aβ production in this context are not yet 
defined, recent evidence suggests that Aβ may exert antimicrobial activities [52, 53].  
 
Astrocyte limitans borders isolate FBRs from neural tissue 
Neural tissue contains several types of glial cells that become reactive around damaged CNS 
tissue and participate in FBRs. Astrocytes are well known to form ‘scars’ that serve as limitans borders to 
isolate CNS lesions [19]. Microglia contribute to border formation and exert phagocytic functions [20] 
while oligodendrocyte progenitors (OPC) proliferate and repair myelin [22]. We identified astrocytes and 
microglia by immunohistochemistry for GFAP and P2RY12 respectively, and OPC by staining for Olig2 
and the reporter protein, td-Tomato (tdT), which had been transgenically-targeted by NG2(Cspg4)-Cre-
ERT2 [54]. We compared combinations of markers and probed blood-brain barrier (BBB) integrity at one 
and six weeks after hydrogel injection or L-NIO stroke (Figs. 6,7). 
GFAP-positive astrocytes had begun to form distinct borders around all hydrogel deposits by one 
week after injections, and these borders persisted and consolidated by six weeks. Astrocyte borders 
around hydrogels were similar in appearance to borders formed around L-NIO infarcts and clearly 
segregated persisting hydrogel material and CD13-positive stromal and inflammatory cells from neural 
tissue containing NeuN-positive neurons (Figs. 1c,d;2a,b;6a,b;7a,b). Notably, astrocyte borders adjacent 
to DCHMO and other nonionic hydrogels interfaced directly with gel surfaces with limited intervening 
fibrosis or inflammation, whereas astrocyte borders adjacent to DCHK and other cationic gels or L-NIO 
interfaced with stromal and inflammatory cells (Figs. 2a,b,4,6a,b). Astrocyte borders around hydrogels 
and L-NIO infarcts were similar in appearance to astrocyte limitans borders that separate healthy neural 
tissue from non-neural stromal cells along all interfaces of normal CNS with meninges (Supplementary 
Fig. 1c) [55]. Astrocyte border thickness at six weeks was proportionally greater with increasing severity 
of FBR, such that DCHMO displayed the thinnest astrocyte borders while DCHK and L-NIO both had 
similar sized borders of more than double the thickness (Fig. 7e). Across all conditions at six weeks, 
lateral astrocyte borders formed by grey matter astrocytes, were thinner compared to medial borders that 
recruited white matter astrocytes from the internal capsule (Figs. 1b,7a-b,e). 
Neural parenchyma extending from astrocyte borders exhibited initially moderate astrocyte 
reactivity indicated by elevated GFAP, which declined significantly over time and by six weeks was 
minimal in all cases (Fig. 6a,b;7a,b). Reactive microglia and OPC intermingled with astrocytes along 
borders and adjacent neural tissue, but did not infiltrate into hydrogels or contribute to volumes of CD13-
positive fibrosis and inflammation at any timepoint examined (Fig. 6a-d and Supplementary Fig. 11a). At 
six weeks a thin, single cell layer of non-neural tissue (CD13-positive) that expressed stromal cell 
markers PDGFRβ and fibronectin interfaced directly with DCHMO and the astrocyte limitans border 
(Supplementary Fig. 11b) while these cells contributed to large volumes of non-neural fibrotic tissue in 
DCHK and L-NIO strokes (Supplementary Fig. 11b,c).   
Astrocyte border formation is essential for re-establishing BBB integrity after CNS injuries [30]. To 
probe BBB integrity adjacent to hydrogel deposits, we stained for mouse immunoglobulin (IgG) and 
albumin, the two most abundant serum proteins [30]. As expected, after one week and prior to border 
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formation [30], IgG and albumin staining were increased in neural parenchyma around hydrogel 
injections and L-NIO stroke lesions, and were significantly higher around DCHK, compared with DCHMO 
(Fig. 6e,f; Supplementary Fig. 12a-c). By six weeks, serum protein levels around DCHMO were 
indistinguishable from those in uninjured tissue and were restricted to a thin layer of non-neural tissue 
that interfaced with the astrocyte limitans border. In contrast, around L-NIO stroke lesions and cationic 
DCHK, serum proteins remained significantly elevated in neural tissue at six weeks (Fig. 6e,f, 
Supplementary Fig. 12a-c).  
 
Fig. 6 | Astrocytes form limitans borders that isolate hydrogels and non-neural FBR components from viable neural 
tissue. a,b. Progression of astrocyte limitans border formation from 1 week (a) to 6 weeks (b) for DCHMO, DCHK, and L-NIO-
induced stroke. c,d. OPC identified by NG2-targeted reporter (tdT) (c) and Olig2 (d) intermingle with GFAP-positive astrocytes 
and do not migrate into CD13-positive regions. e. Comparison of extent of blood brain barrier (BBB) disruption and repair as 
measured by IgG staining around DCHMO and DCHK deposits at 1 and 6 weeks after injection. f. Quantification of the percentage 
increase in IgG levels in the hydrogel injected caudate putamen (CP) normalized to the non-injected contralateral side. **P < 0.001 
and ***P < 0.0001 for DCHK versus DCHMO at 1 week and 6 week respectively and NS for DCHK samples between the two time 
points, two-way ANOVA with Bonferroni. Graph shows mean ± s.e.m with individual data points showing n mice per group.  (one 
column width figure) 
 
These findings show that astrocytes rapidly form limitans borders around hydrogels in a manner 
similar to borders formed around ischemic or traumatic tissue damage, or that exist along meningeal 
non-neural stromal tissue around healthy CNS. Astrocytes, microglia and OPCs become reactive in 
neural tissue adjacent to hydrogel deposits or stroke lesions, but do not migrate into the non-neural 
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fibrotic tissue compartments that persist chronically. Glial reactivity and BBB leakiness into neural tissue 
adjacent to astrocyte borders persist longer adjacent to cationic materials that generate substantial 
inflammation and fibrosis compared with nonionic materials that do not.   
 
FBR determines hydrogel resorption or persistence 
To evaluate the relationship between FBR and hydrogel resorption or persistence, we compared 
nonionic DCHMO and cationic DCHK deposits at various times after injection (Figs. 1,7). Quantification 
showed that after 48 hours, DCHMO and DCHK exhibited deposits of similar size. After one week, DCHMO 
deposits had decreased in size by 30%, but remained at this size after six weeks and persisted 
essentially unchanged after twelve weeks (Figs. 7a-d,f). In contrast, after one week DCHK deposits had 
decreased in size significantly by over 50% and continued to steadily decrease in size until there was no 
detectable deposit remaining at 6 weeks (Fig. 7a,b,f). Over time, DCHMO exhibited no increase in CD13 
levels above baseline, whereas DCHK evoked a steadily increasing infiltration of CD13-positive 
inflammatory and stromal cells that proceeded in a concentric fashion from hydrogel-tissue interfaces 
inwards until the entire deposit was consumed (Figs. 1c,d,3a,4b,7a,b,g; Supplementary Fig. 7a). By 
comparison, the wound response to L-NIO-induced ischemia attracted a pronounced infiltration of CD13-
positive cells that rapidly filled the entire volume of damaged tissue and then persisted (Figs. 1c,d,7a,b). 
These findings show that DCHMO and other nonionic hydrogels persist and are not efficiently resorbed in 
vivo because they do not attract sufficient CD13-positive phagocytes. In contrast, DCHK and other 
cationic hydrogels attract these phagocytic leukocytes to their interfaces with host tissue and are 
gradually resorbed from the outside in and become replaced by fibrosis. DCHMM was an exception to this 
general cationic hydrogel resorption trend and instead showed minimal hydrogel resorption after 3 weeks 
(Supplementary Fig. 7c). This chronic hydrogel persistence coupled with the unresolved Lys6B2-positive 
neutrophils at the material-tissue interface suggests that DCHMM is unable to be readily cleared due to 
frustrated phagocytosis. Thus, hydrogel properties determine FBR features, which in turn determine 
hydrogel resorption or persistence.   
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Fig. 7 | Hydrogel FBR with recruitment of CD13 positive cells leads to hydrogel resorption. a,b. Survey and detail images 
show qualitative reductions in size of DCHK deposit and L-NIO-induced infarct, but not of DCHMO deposit at 6 weeks after injection 
c,d. Survey and detail images show DCHMO deposit remains largely unresorbed up to 12 weeks after injection. e. Quantification 
of GFAP positive cell border thickness (measurement of half width maximum of GFAP intensity curve) at the lateral (grey matter) 
or medial (internal capsule) borders at 6 weeks. *P<0.05 and **P < 0.003 and ***P < 0.0001 versus DCHMO on same side; NS 
between DCHMO on either side, **P < 0.003 for border location effect across all samples, two-way ANOVA with Tukey. f. 
Quantification of change in hydrogel radius for DCHMO and DCHK from 2 to 42 days. NS, **P < 0.003 and ***P < 0.0001 for DCHK 
versus DCHMO at 2, 7 and 42 days; NS for DCHMO at 7 versus 42 days, two-way ANOVA with Bonferroni. g. Quantification of 
change in total CD13 for DCHMO and DCHK from 2 to 42 days. **P < 0.007 and ***P < 0.0001 for DCHK versus DCHMO at the same 
timepoints. NS between the various time points for DCHMO, two-way ANOVA with Bonferroni. h. Schematic of microgel particle 
(MP) synthesis involving the inverse emulsion of polyethylene glycol (PEG)-based thiol and acrylate functionalized oligomers that 
react via Michael addition. MP can be readily suspended in physical hydrogels tested. i,j. Survey images of FBR to DCHMO loaded 
with MP at 1 week and 6 weeks show that incorporation of MP into DCHMO leads to recruitment of CD13 positive cells and hydrogel 
resorption. k. Quantification of the effect of incorporation of MP (+) on total CD13 positive cell response for DCHMO and DCHK at 
1 week. NS and ***P < 0.0001, two-way ANOVA with Bonferroni. All graphs show mean ± s.e.m with individual data points showing 
n mice per group. (two column width figure) 
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Microparticles alter FBR and hydrogel resorption 
Incorporating nano/microparticles into hydrogels may be a useful tool to enhance the control of 
delivery of multiple and diverse molecular cargos independently from a single construct to the CNS [18, 
56, 57]. Since introduction of particles may alter the physiochemical properties of hydrogels into which 
they are loaded, we examined the effects on FBR and resorption of hydrogels laden with PEG based 
nonionic microparticles (MP) formulated via a standard inverse emulsion thiol-ene Michael addition 
process (Fig. 7h) [58-60]. MP, with an average diameter of 3.3 µm, imparted a modest increase in 
mechanical properties to DCH but did not alter injectability (Supplementary Fig. 13a-f). MP at high 
concentrations were non-toxic to neural progenitor cells in vitro (Supplementary Fig. 13d). As described 
above, nonionic DCHMO and HAMC on their own evoked minimal fibrotic or inflammatory responses and 
formed long persisting deposits. Addition of nonionic MP to these hydrogels caused pronounced 
recruitment of peripheral inflammatory cell infiltration in the form of both CD13-positive macrophages and 
Lys6B2-positive neutrophils, as well as rapid hydrogel resorption and fibrotic replacement (Figs. 7i-k; 
Supplementary Fig. 13g-k). Nevertheless, the FBR of MP loaded DCHMO did not detectably increase 
acute neural tissue loss or axonal injury (Supplementary Fig. 13g,h). Similar sized non-toxic MP as the 
ones evaluated here (~3 µm diameter) have previously demonstrated a high susceptibility to 
phagocytosis in vitro by macrophages [61]. Incorporating MP into nonionic hydrogels may stimulate 
similar size recognition programs in vivo thus leading to the recruitment of phagocytes by mechanisms 
other than those associated with host neural tissue damage at the hydrogel-host interface as was the 
case for cationic hydrogels. These findings show that adding such MP to hydrogels that would otherwise 
be ignored by phagocytes can induce a phagocytic FBR that steadily resorbs the material and replaces it 
with fibrosis.  
 
FBR alters hydrogel molecular delivery to CNS parenchyma  
To characterize FBR effects on delivery of molecular cargos, we first examined the biodistribution 
of model non-bioactive molecules released into neural tissue adjacent to hydrogel deposits, and second 
evaluated the efficacy of bioactive growth factor delivery. As non-bioactive molecules, we used 
biotinylated dextran amines (BDA) of different molecular weights because they are non-immunogenic, 
fixable, easily detected by immunohistochemistry, and because 10kDa (BDA-10) and 70kDa (BDA-70) 
BDAs exhibit hydrodynamic radii that approximate bioactive protein growth factors and therapeutic 
monoclonal antibodies, respectively [62, 63].  
BDAs injected in PBS are well documented to diffuse locally throughout CNS neural parenchyma 
and along perivascular spaces, and are taken up by neurons as well as by microglial and perivascular 
phagocytic cells in a size dependent manner [64]. A detailed comparison of the biodistributions of BDA-
10 and BDA-70 released from PBS, DCHMO, or DCHK is presented in Supplementary Figures 14-16. 
Briefly, under all conditions, BDAs were detectable only in the ipsilateral hemisphere, and DCHMO, and 
DCHK displayed significant differences both in the depth of penetration of BDAs into neural tissue and in 
cellular uptake. BDAs released from DCHMO were found more concentrated locally near hydrogel 
deposits, with substantial uptake by neurons and some microglial phagocytosis (Supplementary Figs. 
14-16). By contrast, BDAs released from DCHK showed increased radial diffusion, but with limited 
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detectable uptake by neurons and heavy accumulation in microglia and perivascular phagocytes 
(Supplementary Figs. 14-16). These findings suggested that hydrogels with different FBRs exhibit 
differences not only in the distribution of molecular delivery into neural tissue, but also in the type of cells 
that may be primarily targeted.   
We therefore next compared the biodistribution of BDA-10 released from different hydrogels that 
displayed escalating and unique severities of FBR: DCHMO, DCHK, DCHMM and CHIT (Fig. 8a). We 
quantified the proportion of BDA present in the non-neural compartment defined as the area of hydrogel 
deposit and its non-neural surrounding tissue, versus the neural compartment defined as the neural 
tissue surrounding the deposits containing viable neurons and different neuroglia (Fig. 8b-d, 
Supplementary Fig. 17). At 2 weeks after injection, DCHMO, with the least noxious FBR showed the 
highest total delivery of BDA into the neural compartment, and yielded greater uptake in neurons, which 
was highest local to the hydrogel-tissue interface (Fig. 8b-d). DCHK exhibited less neural parenchyma 
delivery than DCHMO but more than DCHMM and CHIT, and BDA was preferentially taken up by microglia 
rather than neurons (Fig. 8e,f). DCHMM and CHIT, which show the most severe FBR (Fig. 3b,d), 
displayed: (i) significantly increased accumulation of BDA in non-neural compartments associated with 
the FBR (Fig. 8b); (ii) reduced uptake of BDA by local neurons (Fig. 8c); and (iii) greater BDA 
accumulation in macrophages (CD13 positive/CD68 positive cells) (Fig. 8e). Notably, DCHK, DCHMM and 
CHIT exhibited pronounced BBB leakage with extended distribution of serum albumin through neural 
parenchyma compared with DCHMO (Supplementary Fig. 17c,d) and degree of BBB leak correlated with 
increased BDA biodistribution throughout the brain and increased inflammatory cell phagocytosis of BDA 
(Fig. 8d,e, Supplementary Fig. 17a). Serum proteins such as albumin bind systemically delivered 
biological materials such as bioactive proteins, small molecule drugs and nanoparticles, and alter their 
biodistribution [65]. In addition, serum proteins are proinflammatory in neural tissue [19, 22]. We also 
evaluated the biodistribution of BDA-10 released from MP that had been loaded into DCHMO. The 
increased non-neural and phagocyte dominated FBR associated with MP inclusion into nonionic DCHMO 
correlated with significantly decreased BDA-10 accumulation in neural tissue at 1 week and extensive 
consumption of BDA-10 by CD13 positive cells (Supplementary Fig. 18). Together, these data show that 
hydrogels with pronounced non-neural FBRs have reduced molecular delivery efficacy to neural tissue 
and that this reduction scales with the severity of the FBR. 
Lastly, we evaluated the effect of FBR on hydrogel-mediated delivery of bioactive molecules in 
vivo. Basal forebrain cholinergic neurons are exquisitely sensitive to nerve growth factor (NGF) levels 
and atrophy when deprived of NGF and hypertrophy when exposed to exogenous NGF (Fig. 8g) [34, 66, 
67]. To compare the efficacy of NGF delivery by various hydrogels, we quantified the size of local striatal 
cholinergic neurons. NGF delivered from DCHMO and DCHK stimulated significant 40% increases in 
ipsilateral cholinergic neuron size relative to uninjected controls, whereas NGF delivered from DCHMM 
and CHIT, which attract a severe non-neural FBR, showed highly variable effects with no overall 
significant increase (Fig. 8h). Incorporating data from across the molecular delivery and FBR phenotype 
characterizations into a Principal Component Analysis (PCA) showed a significant inverse correlation 
between neural tissue molecular delivery efficacy and the severity and intensity of hydrogel FBR-
associated inflammation (Fig. 8i,j, Supplementary Fig. 19).   
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Fig. 8 | Hydrogel FBR alters CNS Molecular delivery. a. Detail images of BDA (10kDa) biodistribution released from DCHMO, 
DCHK, DCHMM, and CHIT at 2 weeks. b. Quantification of BDA in tissue compartments adjacent to hydrogels. ***P < 0.0001 versus 
DCHMO; NS not significant c. Quantification of the normalized number of BDA-positive neurons at 2 weeks. *P < 0.05, NS versus 
DCHMO. d. Quantification of the radial distance to the 50% percentile BDA-positive neuron from the hydrogel-tissue interface. 
***P < 0.0001 versus DCHMO. e. Quantification of BDA-positive inflammatory cells at 2 weeks. *P < 0.005, **P < 0.001, 
***P < 0.0001 versus DCHMO. f. Detail images showing phenotype of BDA positive cells adjacent to hydrogel deposits. g. Detail 
images showing increase in cholinergic (ChAT-positive) neuron size in striatum by NGF delivered from DCHMO. h. Quantification 
of the increase in cholinergic neuron size normalized to the contralateral side at 1 week after injection of NGF releasing hydrogels. 
***P < 0.0001 and **P < 0.005 versus DCHMO, NS for DCHMM and CHIT versus untreated, *P < 0.05 for DCHMM and CHIT versus 
DCHK, NS between DCHMO and DCHK. i. Principal Component Analysis (PCA) for DCHMO, DCHK, DCHMM, and CHIT hydrogels 
incorporating data from molecular delivery and immunohistochemistry evaluations. j. Graphical representation of the positions of 
hydrogels along PC1 axis (accounting for 64.22% of total variance) with the positive direction representing effective neural 
molecular delivery while the negative direction represents molecular delivery to inflammatory cells, ***P < 0.0001 for all versus 
DCHMO, ***P < 0.0001 for DCHK versus DCHMM and CHIT, NS for DCHMM versus CHIT. For all graphs, data are mean ± s.e.m with 
individual data points superimposed over bar graphs showing n mice per group. Statistical analysis using one or two-way ANOVA 
with Bonferroni where appropriate.  (two column width figure)   
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These findings show that delivery of molecular cargo from hydrogels to CNS tissue is influenced 
by the nature and severity of the material-evoked FBR (Fig. 9). In particular, an increased recruitment of 
peripherally derived phagocytes into hydrogel deposits results in increased consumption of cargo 
molecules and reduced neural tissue delivery. Further, a minimal hydrogel FBR with little or no BBB 
leakage results in very local delivery with a higher proportion of targeting of cargo molecules to neurons. 
In contrast, more severe FBRs with pronounced BBB leakage contributes to increased dispersal of 
delivered molecules throughout larger volumes of neural parenchyma, and to greater targeting of those 
molecules to phagocytosis by microglia and perivascular cells.  
 
 
Fig. 9 | Schematic summarizing the main findings of this study: CNS FBRs mimic the natural wound healing response to CNS 
tissue injury as it progresses over time (t) from acute to chronic stages (top to bottom). CNS FBRs to biomaterials exist on a 
severity spectrum (left to right) that is dependent on definable material properties such as the biomaterial chemistry presented to 
the host at the biomaterial-tissue interface. CNS FBR phenotype and its severity alter hydrogel function in terms of molecular 
delivery and biomaterial resorption. (two column width figure)   
 
Discussion 
Here, we show that CNS FBRs to biomaterials mimic CNS wound responses and exist on a 
severity spectrum that is determined by definable chemical functionalities perceived by the host at the 
biomaterial-tissue interface. Moreover, the nature and severity of FBRs significantly affect multiple 
aspects of biomaterial function. These findings have broad implications for developing, testing and using 
biomaterials for CNS applications, and also for understanding the conserved biology of the CNS wound 
response and astroglial limitans border formation. We provide a framework for comprehensively 
evaluating in vivo responses to biomaterials for CNS applications, which may facilitate the development 
and characterization of new and improved systems.  
As a platform to study CNS FBRs evoked by definable chemical functionalities presented to host 
cells by biomaterials, we used readily modified synthetic hydrogels whose direct interfaces with host 
cells can sensitively and intimately be evaluated in vivo. Our findings show that specific physiochemical 
properties presented at biomaterial-host interfaces, such as cationic, anionic or nonionic interfaces with 
CNS cells, evoke quantifiably different FBR phenotypes with respect to levels of stromal cell infiltration, 
inflammation, tissue fibrosis, astroglial border formation and BBB disruption. Moreover, we show that 
FBRs evoked by materials in CNS are directly related to, and mimic, the multicellular CNS wound 
response to tissue injury (modeled here by the response to an ischemic infarct), and are best understood 
in the context of this conserved biology. Trauma, ischemia, autoimmune attack and infections all 
generate potentially toxic cellular debris that trigger multicellular wound responses as naturally occurring 
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events. The conserved CNS wound response serves to recruit inflammatory cells that degrade toxic 
elements and also simultaneously serves to isolate damaged tissue, debris and inflammation from 
adjacent viable neural tissue and to restore barrier functions important for normal CNS function [19, 22, 
55]. In this manner, naturally occurring CNS wound responses give rise to discrete lesion compartments 
with central cores of non-neural tissue surrounded by astrocyte limitans borders that are continuous with 
spared and reorganizing neural tissue. This compartmentalized organization is mimicked by FBRs 
evoked by biomaterials (Fig. 9). The specialized multicellular and compartmentalized CNS wound 
response or FBR is not present in peripheral tissues, and thus evaluation of biomaterial FBR in 
peripheral tissue alone is not sufficient to predict performance in the CNS. Naturally occurring CNS 
wound responses exist on a severity spectrum that varies with: (i) the degree of the tissue damage, (ii) 
the nature and the toxicity of debris, and (iii) the presence or absence of microbes or their associated 
signals. Similarly, the nature and severity of FBRs to biomaterials vary with the molecular features of the 
interface presented to host tissue. 
Our findings emphasize the need for use of multiple markers to assess multiple FBR dimensions, 
including markers of stromal, inflammatory, multiple glial cells, neural tissue damage and fibrosis. We 
show that GFAP, a commonly used marker of astrocyte reactivity that can indicate tissue pathology [19], 
is on its own not a sufficient or reliable marker to evaluate and differentiate material or device FBRs. For 
example, we show that total GFAP levels are essentially indistinguishable in neural tissue within close 
proximity to biomaterials that evoke markedly different FBR severities, including FBRs that evoke 
pronounced levels of inflammation and fibrosis that impact significantly on function. Our findings provide 
a framework of multiple molecular markers and experimental tools for comprehensive evaluation of 
material FBRs in the CNS in vivo using readily available immunohistochemical reagents that can be 
applied to benchmark the performance of new biomaterial formulations against various well 
characterized formulations used here.  
We also show that the nature and severity of FBRs strongly influence biomaterial function in the 
CNS as studied here in the form of rate of hydrogel resorption, biodistribution of molecular cargo delivery 
to neural parenchyma and efficacy of bioactive molecular delivery. Thus, developing hydrogels and other 
biomaterials with efficient functions for CNS applications will require a detailed understanding of their in 
vivo FBRs. In vitro evaluations of molecular release dynamics are on their own insufficient to predict 
efficacy of molecular delivery in the CNS in vivo, because delivery will be strongly influenced by CNS 
specific FBRs. For example, we show that microparticles that significantly extend molecular release 
duration from hydrogels in vitro can attract phagocytes in vivo that significantly reduce molecular delivery 
compared with the hydrogels they are suspended in. Notably, our findings indicate that hydrogel 
formulations with features that attract phagocytic cells such as blood borne macrophages and 
neutrophils will have particularly poor functional performance in molecular delivery to host tissue (and 
most likely also as vehicles for cell grafts). Moreover, we show that these hydrogel features may not be 
revealed by solely examining the glial response of more distant surrounding neural tissue, because 
hydrogel deposits are rapidly and effectively isolated as part of the FBR, which mimics naturally 
occurring wound responses that maximize the protection of adjacent neural tissue [19, 22]. 
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In this study we used hydrogels as surrogate biomaterials to characterize host responses to 
specifically presented chemical functionalities, and molecular delivery from hydrogels was the primary 
functional outcome measure evaluated. The basic principles we identified can inform the development of 
materials for a variety of CNS applications including implantable neuroprostheses for recording and 
stimulating neural circuit activity [2, 3, 23, 68]. For example, we show that surface charge at the material-
host interface influences the severity of FBRs, which in turn will influence the degree of protective fibrotic 
and astrocyte barrier formation that forms to isolate the materials from adjacent neural tissue and may 
thereby attenuate function. Thus, such devices will also benefit from detailed characterization of FBRs as 
described here. While the bulk of implantable neuroprostheses most frequently employed in human and 
non-human primate studies currently make use of non-resorbable, hydrophobic polymers that may 
stimulate unique FBR phenotypes in addition to that described here [23], emerging systems are opting 
for hydrophilic, hydrogel-based coatings/substrates with comparable chemistries to this study [69, 70]. 
Thus, it would seem particularly appropriate to apply the FBR evaluation framework outlined here to 
these new formulations as part of preclinical testing protocols moving forward. Furthermore, 
incorporating the identified hydrogel chemical functionalities that evoked minimal FBRs (e.g. methionine 
sulfoxide functional groups from DCHMO) into future neural electrode design may be a useful strategy in 
attenuating the thickness of disrupted tissue and the intensity of the astroglial border-forming response 
between the device and viable neural tissue.  
Lastly, our findings inform the understanding of CNS wound responses by demonstrating and 
characterizing how FBRs fall firmly within the framework of the conserved multicellular biology of such 
responses. In this regard, we also add to the growing evidence [48-53] that APP accumulation and the 
acute formation of Aβ are consequent responses to neural tissue injury that occur in direct proportion to 
the level of neuronal and axonal damage, and are thus part of the conserved biology of CNS wound 
responses and FBRs. 
In conclusion, we show that material FBRs are determined by definable properties presented at 
host interfaces, which can be modified to minimize or evoke specific responses. Understanding these 
properties and the CNS specific FBRs that they evoke in vivo will be critical to designing new materials 
for diverse CNS applications. In addition, this observation raises the intriguing prospect of engineering 
biomaterials with originally inert profiles to present specific molecular features in order to dissect cell-
surface and contact-mediated molecular mechanisms that drive specific elements of naturally occurring 
CNS wound responses.   
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Methods 
 
Animals 
All in vivo experiments involving the use of mice were conducted according to protocols approved 
by the Animal Research Committee (ARC) of the Office for Protection of Research Subjects at University 
of California Los Angeles (UCLA). All in vivo animal experiments were conducted within approved UCLA 
facilities using wildtype or transgenic C57/BL6 female and male mice that were aged between 8 weeks 
and four months old at the time of craniotomy surgery. Transgenic td-Tomato (tdT) reporter mice were 
bred with inducible Cre lines to identify Astrocytes (Aldh1L1-Cre-ERT2) and NG2 cells (NG2-Cre-ERT2). 
Transgenic mice (aged between 6 and 12 weeks) were administered tamoxifen to induce Cre 
expression. Tamoxifen in corn oil at a concentration of 20mg/ml was administered via intraperitoneal (IP) 
injection for 5 days at a dose of 50mg/kg per day. Following the last dose of tamoxifen, mice were kept 
for 3 weeks before undergoing surgery for hydrogel injection to allow residue tamoxifen to clear out of 
the mouse’s system. Mice were housed in a 12-hour light/dark cycle in a specific pathogen-free facility 
with controlled temperature and humidity and were provided with food and water ad libitum.  
 
Surgical procedures for mice 
All surgical procedures were approved by the UCLA ARC and conducted within a designated 
surgical facility at UCLA. Hydrogel brain injections were performed on mice under general anesthesia 
achieved through inhalation of isoflurane in oxygen-enriched air. Prior to incision, the mouse head was 
stabilized and horizontally leveled in a rodent stereotaxic apparatus using ear bars (David Kopf, Tujunga, 
CA). A small craniotomy was performed using a high speed surgical drill and visually aided by an 
operating microscope (Zeiss, Oberkochen, Germany). Hydrogel injections were made in the brain using 
pulled borosilicate glass micropipettes (WPI, Sarasota, FL, #1B100-4) that were ground to a 35° beveled 
tip with 150–250 μm inner diameter. Glass micropipettes were mounted to the stereotaxic frame via 
specialized connectors and attached, via high-pressure polyetheretherketone (PEEK) tubing, to a 10 μL 
syringe (Hamilton, Reno, NV, #801 RN) that was controlled by an automated syringe pump (Pump 11 
Elite, Harvard Apparatus, Holliston, MA). Each hydrogel was backloaded into the micropipette prior to 
connecting to the stereotaxic frame. A volume of 1 μL of hydrogel was injected into the caudate putamen 
nucleus at 0.15 μL/min using target coordinates relative to Bregma: +0.5 mm A/P, +2.5 mm L/M and 
−3.0 mm D/V. For the NGF delivery studies target coordinates relative to Bregma: +1 mm A/P, +2.2 mm 
L/M and −3.0 mm D/V were used. The micropipette was allowed to dwell in the brain at the injection site 
for an additional 4 minutes at completion of hydrogel injection. The micropipette was then removed from 
the brain slowly and incrementally over a 2 minute period.  
 
Synthesis and formulation of hydrogels 
Physically crosslinked hydrogels were formulated from polypeptide or polysaccharide polymers 
(Figure 1a, Supplementary Fig. 3 a,b) that were synthesized using procedures developed previously by 
our group or purchased from commercial sources and used as received.  
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Preparation of Diblock Copolypeptide Hydrogels (DCH) 
The polypeptides were prepared using synthetic schemes reported previously. Specific and 
detailed synthetic protocols for preparing DCHMO, DCHK, DCHMM, DCHE, DCHMOK10, DCHMOE15 have been 
provided across a number of previous peer reviewed publications [8, 25, 34].   
 
DCHMOE15 was prepared for the first time as part of this current work and the method for 
synthesizing this polypeptide can serve as a general overview for polypeptide synthesis. Polypeptide 
synthesis was performed in a N2 filled glove box using anhydrous solvents. Amino acid N-
carboxyanhydride (NCA) monomers including tert-butyl-L-glutamate NCA, L-methionine NCA, L-leucine 
NCA were prepared by phosgenation of a tetrahydrofuran (THF) solution of the corresponding amino 
acid in a Schlenk flask under N2 and purified by either recrystallization or column chromatography as 
outlined before. To prepare copolypeptides at ca. 100 mg scale, a solution of initiator, Co(PMe3)4, (3.5 
mg, 0.001 mmol) in THF (20 mg/mL) was quickly added to a mixture of L-methionine NCA (Met NCA; 
100 mg, 0.57 mmol) and tert-butyl-L-glutamate NCA (tert-butyl Glu NCA; 23 mg, 0.10 mmol) in THF (50 
mg/mL). After 2 hours, complete consumption of NCA was confirmed by Fourier-transform infrared 
(FTIR) spectroscopy. In order to determine the lengths of poly(L-methionine-stat-tert-butyl-L-glutamate)m, 
(MEtB)m, segments, a small aliquot (200 µl) of polymerization mixture was removed, reacted with α-
methoxy-ω-isocyanoethyl-poly(ethylene glycol)45 (mPEG23-NCO) and chain length determined by end-
group analysis using 1H NMR. To the remaining copolymerization mixture L-leucine NCA (Leu NCA; 14 
mg, 0.088 mmol) in THF (50 mg/mL) was then added. The Leu NCA monomers were found to be 
completely consumed within approximately 1 hour, and the reaction mixture was subsequently removed 
from the glove box. The block copolypeptide solution was then precipitated by addition to a DI water 
solution (75 mL), filtered, washed with DI water, and dried under reduced pressure to obtain a white fluffy 
solid (91 mg, 95% yield).   
The deprotection of tert-butyl-L-glutamate residues was performed before the oxidation of L-methionine 
residues. To facilitate deprotection, (MEtB)170L24 (ca. 80 mg) was fully dissolved in trifluoroacetic acid (ca. 
25 mg/mL) and stirred at ambient temperature for 16 hours. The copolypeptide was then precipitated into 
diethyl ether (75 mL). The diethyl ether was decanted and the copolypeptide was dried under reduced 
pressure overnight to yield a white solid (ca. 74 g, 99% yield, 97% deprotection efficiency). To convert L-
methionine residues in copolypeptides to L-methionine sulfoxide residues, a volume of 70 wt. % tert-
butyl hydroperoxide (TBHP) (16 molar equivalents per L-methionine residue) was added to a sample of 
solid copolypeptide (ca. 80 mg). The reaction mixture was then diluted with DI water to yield an overall 
polypeptide concentration of 20 mg/mL. To aid oxidation, a catalytic amount of camphorsulfonic acid 
(CSA) (0.2 molar equivalents per Met residue) solution in DI water (20 mg/ml) was subsequently added. 
The reaction mixture was stirred vigorously for 24 hours at ambient temperature, whereupon complete 
dissolution of the copolypeptide sample was observed. Reaction mixtures were transferred to 2000 
MWCO dialysis bags and dialyzed against: (i) pyrogen free deionized milli-Q water (3.5 L) containing 
sodium thiosulfate (1.2 g, 2.2 mM) for 1 day to neutralize residual peroxide, (ii) pyrogen free deionized 
milli-Q water (3.5 L) containing ethylenediaminetetraacetic acid tetrasodium salt hydrate (1.0 g, 2.63 
mmol) to aid cobalt ion removal, (iii) pyrogen free deionized milli-Q water (3.5 L) which was adjusted to 
All rights reserved. No reuse allowed without permission. 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/797092doi: bioRxiv preprint first posted online Oct. 8, 2019; 
25 
pH 8 with 1.0 M NaOH  and contained sodium chloride (5 g, 85.5 mmol) for 2 days to aid in counter ion 
exchange of glutamate residues, and (IV) pyrogen free deionized milli-Q water (3.5 L) for 2 days to 
remove residual ions. For each step dialysate was changed every 12 hours. The copolypeptide solution 
was then freeze dried to yield a white fluffy solid (ca. 85 g, 95% yield, and 100% conversion of L-
methionine residues in copolypeptides to L-methionine sulfoxide groups).  
 
All DCH variants were prepared by solubilizing lyophilized copolypeptide in phosphate buffered saline 
(PBS) and leaving to assemble for 24 hours, without stirring, before use. All DCH formulations were 
prepared at 4.0 wt% in PBS.  
 
Preparation of Polysaccharide based hydrogels.  
Polysaccharide based hydrogels of chitosan, methyl cellulose (MC) and hyaluronic acid/methyl 
cellulose blend (HAMC) were prepared following procedures detailed in the literature. To formulate 
chitosan hydrogels, solutions of chitosan [MW= 50,000-190,000 Da; DDA≈85%] (Sigma, #448869) in 
0.1M acetic acid were prepared at 2.3 % (w/v) and allowed to dissolve overnight at 4°C [33]. A 50% w/v 
or 2.314 M solution of β-glycerophosphate disodium salt (β-GP) (Sigma, #G9422) in water was 
subsequently added dropwise to the chitosan solution on ice and manually stirred to form a uniform 
solution and elevate the solution pH to 7.4. Prior to surgical micropipette loading, the chitosan hydrogel 
was incubated at 37°C for one hour to initiate physical gelation. Methylcellulose (Methocel A15C, [MW = 
304 kDa; 27.5-31.5% substitution], Sigma #64625) hydrogels were prepared by dispersing and then 
solubilizing at 4°C at a concentration of 4 wt% [31]. The HAMC hydrogel was prepared by dispersing a 
measured amount of hyaluronic acid [1.01-1.8 MDa] (Lifecore Biomedical, #HA15M-1) into a pre-
dissolved 4wt% MC solution and allowed to dissolve at 4°C overnight. The HAMC blended hydrogel 
used for in vivo studies had a concentration of 1% HA and 3% MC which was equivalent that used 
previously within in vivo CNS studies [32].  
 
For BDA delivery experiments, appropriate volumes of 10% w/v stock solutions of BDA (10kDa – 
Thermofisher, #D1956 or 70kDa – Thermofisher, # D1957) in PBS were added to the polymer solutions 
to net a final concentration of 1% BDA in hydrogels. For NGF delivery experiments, lyophilized 
recombinant human β-NGF (PeproTech, Cat# 450-01, Rocky Hill, NJ) was reconstituted in PBS and 
added to the polymers to form hydrogels with a final concentration of NGF of 1 mg/mL.  
 
Microgel Microparticle Synthesis 
Microparticles based on polyethylene glycol (PEG) microgels were derived by covalently reacting 
ethoxylated trimethylolpropane (TMPE) oligomers functionalized with either acrylate or thiol acid ester 
groups under physiologically buffered conditions by thiol-ene Michael Addition as reported before [58]. A 
standard inverse emulsion (IE) technique was applied to formulate microgels whereby aqueous buffer 
solubilized oligomers were dispersed in a larger volume mineral oil bath that contained the nonionic 
sorbitan alkyl ester surfactant, Span 83, to create a stable emulsion and direct microgel size [59, 60]. 
The emulsion was stirred for one hour at room temperature on a magnetic stir plate before being washed 
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and centrifuged three times with hexanes to remove the mineral oil and surfactant. Collected 
microparticles were dried under high vacuum to evaporate residual hexane solvent. Microgels were 
uniformly dispersed in PBS at 6 wt% using a pellet pestle mixer and added to hydrogel solutions to a 
final concentration of 3 wt%. For BDA delivery experiments, appropriate volumes of 10% BDA-10 stock 
were added to the aqueous reaction buffer during microgel synthesis to load microgel particles with BDA.  
 
Hydrogel and Microparticle Characterization  
 
Dynamic Mechanical Rheology 
Dynamic rheological measurements were performed at constant set temperature of 25 °C using a 
Physica MCR 301 (Anton Paar, Sweden) equipped with a 25 mm 1° cone and plate geometry.  To 
determine the linear viscoelastic testing region for each DCH sample a frequency sweep from 0.1 to 100 
rad s-1 at a fixed strain of 0.5% was applied followed by a strain sweep from 0.1 to 100% strain at a fixed 
frequency of 10 rad s-1. DCH samples were allowed to recover for a period of 2 minutes between 
individual rheological experiments. To compare mechanical properties across various DCH samples a 
time sweep under fixed strain and frequency conditions (0.5% strain and 10 rad s-1) was applied for one 
minute.  
 
Zeta potential Measurement 
K170 (hydrophilic block of DCHK), (MOA)170 (hydrophilic block of DCHMO), and (MMA)170 (hydrophilic 
block of DCHMM), were dissolved at 15 mg/mL in a 20 mM phosphate buffer solution at pH 7.4 which was 
filtered through a 0.45 µm membrane syringe filter. Mean zeta potentials were analyzed using a 
Zetasizer NanoZS instrument (Malvern Instruments Ltd., United Kingdom). Samples were analyzed in 
monomodal mode where fast field reversal (FFR) technique was applied and the electrophoretic mobility 
was calculated using the Henry equation. Sample were prepared in triplicate and analyzed 3 times.  
 
Fourier Transform Infrared Spectroscopy (FTIR) 
Dried microparticles were analyzed by FTIR to confirm the presence of the crosslinked 
ethoxylated polyol network. Several milligrams of dried microparticles were analyzed by attenuated total 
reflection Fourier transform infrared (ATR‐FTIR) spectroscopy using a PerkinElmer Spectrum One 
instrument equipped with a universal ATR assembly. The ester stretch (≈1730 cm−1) and the loss of the 
acrylate C=C stretch (1675–1600 cm−1) were used to confirm presence of the covalent crosslinked 
network [58].   
 
Differential interference contrast (DIC) microscopy 
To visualize and quantify the size of formulated microparticles a 1mg/ml solution of dispersed 
microparticles was placed on a glass slide, coverslipped and imaged on a Zeiss Axioplan 
photomicroscope using a 63X oil objective. Quantification of microparticles size was performed on 
images taken from several separately prepared slides using NIH Image J (1.51) software.  
 
All rights reserved. No reuse allowed without permission. 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/797092doi: bioRxiv preprint first posted online Oct. 8, 2019; 
27 
Immunohistochemistry 
After terminal anesthesia by barbiturate overdose mice were perfused transcardially with 
heparinized saline and 4% paraformaldehyde. Brains were immediately dissected after perfusion and 
post-fixed in 4% PFA for 6 hours. Brains were cryoprotected in 30% sucrose in TBS for at least 3 days 
with the sucrose solution replaced once after 2 days. Coronal brain sections (40 µm thick) were cut using 
a Leica CM3050 cryostat. Brain sections were stored transiently in TBS buffer at 4°C or in antifreeze 
solution of 50% glycerol/30% Sucrose in PBS at -20°C for long term storage. Brain sections were 
processed for immunofluorescence as described previously [4, 5]. The primary antibodies used in this 
study were: rabbit anti-GFAP (1:1000; Dako, Santa Clara, CA); rat anti-GFAP (1:1000, Thermofisher, 
Grand Island, NY); rabbit anti NeuN (1:1000, Abcam, Cambridge, MA); guinea pig anti-NeuN (1:1000, 
Synaptic Systems, Goettingen, Germany); goat anti-CD13 (1:200, R&Dsystems, Minneapolis, MN); 
rabbit anti-Laminin 1 (1:100, Sigma, St.Louis, MO); rabbit anti-Fibronectin (1:500, Millipore, Burlington, 
MA); rabbit anti-Collagen 1a1 (1:300, Novus Biologicals, Littleton, CO); rabbit anti-RFP (1:1000, 
Rockland, Limerick, PA); goat anti-Albumin (1:300, Novus Biologicals, Littleton, CO); rat anti-PECAM-1 
(1:200, BD Biosciences, San Jose, CA); rat anti-Galectin-3 (1:200, Invitrogen-Thermofisher Scientific, 
Grand Island, NY); rat anti-CD68 (1:1000, AbDserotec-BioRad, Hercules, CA); rat anti-CD45 (1:100, BD 
Biosciences, San Jose, CA); rabbit anti-Iba-1 (1:800, Wako, Osaka, Japan); guinea pig anti-Iba-1 (1:800, 
Synaptic systems, Goettingen, Germany); Rabbit anti-P2Y12R (1:500, Anaspec, Fremont, CA); rabbit 
anti-mouse IgG (1:1000, Abcam, Cambridge, MA); rat anti-Ly6B2 (1:200, Bio-Rad, Hercules, CA); Goat 
anti-PDGFR-β (1:200, R&Dsystems, Minneapolis, MN); and rabbit anti-Olig2 (1:200, Millipore, 
Burlington, MA). BDA was visualized with streptavidin-HRP plus Tyr-Cy3 (Perkin Elmer) as before [4]. 
Nuclei were stained with 4',6'-diamidino-2-phenylindole dihydrochloride (DAPI; 2ng/ml; Molecular 
Probes). Sections were coverslipped using ProLong Gold anti-fade reagent (InVitrogen, Grand Island, 
NY). Sections were examined and photographed using epifluorescence microscopy, deconvolution 
fluorescence microscopy and scanning confocal laser microscopy (Zeiss, Oberkochen, Germany). Tiled 
scans of individual whole sections were prepared using a x20 objective and the scanning function of a 
Leica Aperio Versa 200 Microscope (Leica, Wetzlar, Germany) available in the UCLA Translational 
Pathology Core Laboratory. 
 
Quantification of Immunohistochemistry 
Immunohistochemical staining intensity quantification was performed on whole brain images 
derived from the slide scanner or tiled images prepared on the epifluorescence microscope. All images 
used for each comparable analysis were taken at a standardized exposure time and used the 
raw/uncorrected intensity setting. Quantification of antibody staining intensity for the individual hydrogels 
was performed using NIH Image J (1.51) software and the Radial Profile Angle plugin. The procedure for 
determining the hydrogel radius and the non-neural and neural compartments is outlined graphically in 
Supplementary Fig. 2. Briefly, a radial profile field of 900µm (~846 pixels) was applied to each hydrogel 
(this standardized radial profile field was determined as the average field that included all hydrogels and 
was confined within the caudate putamen region of the brain section (i.e. between the ventricle and 
corpus callosum)). The radial profile analysis determines the average pixel intensity value across the 
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circumference of a circle at each radial pixel distance. The Hydrogel radius/start of tissue location was 
determined from the DAPI profile and specifically where the first derivative (dI/dx) of the DAPI profile 
crossed a threshold of +0.2. The non-neural/neural tissue boundary was defined as the maximum of the 
GFAP intensity which was determined where dI/dx equaled zero. Total values for CD13, GFAP, Ly6B2, 
Col1a1, Gal-3, Albumin, IgG, Iba-1, BDA stainings were determined by taking the integral (Area under 
the curve (AUC)) of the radial intensity profile. Albumin and IgG intensities and total values were 
normalized to the contralateral hemisphere of each animal.  
 
For BDA and NGF delivery quantification only slide scanned images were used. Medial and 
lateral hem-circular radial analysis was performed in addition to the standard radial profile analysis 
described above to quantify BDA dispersion throughout whole brain sections. Quantification of the co-
staining of BDA with specific immunohistochemical stains such as NeuN, CD13, CD68, Iba-1, IgG and 
Albumin was performed using the RG2B colocalization plugin in NIH Image J (1.51) software. Number of 
BDA and NeuN positive neurons was determined by counting the number of BDA/NeuN colocalized 
staining puncta using the analyze particles function in NIH Image J (1.51) software. Bioactive NGF 
delivery was assessed by characterizing the size (area) of Choline Acetyltransferase (ChAT) and NeuN 
positive cholinergic neurons also using the analyze particles function in NIH Image J (1.51) software.  
 
Statistics, power calculations, group sizes and reproducibility 
Graph generation and statistical evaluations of repeated measures were conducted by one-way 
or two-way ANOVA with post hoc independent pair wise analysis as per Bonferroni, Tukey, or by 
Student’s t-tests where appropriate using Prism 8 (GraphPad Software Inc, San Diego, CA). Principal 
Component Analysis (PCA) was performed using XLStat (Addinsoft Inc, Long Island City, NY). For one-
way and two-way ANOVA statistical evaluations, P-values, F-values and degrees of freedom are 
reported in the manuscript and within the source data files. Similarly, for Student’s two-tailed t-test, the t 
value and degrees of freedom are reported. Power calculations were performed using G*Power Software 
V 3.1.9.2. For immunohistochemical quantification analysis, group sizes were calculated to provide at 
least 80% power when using the following parameters: probability of type I error (alpha) = .05, a 
conservative effect size of 0.25, 3-10 treatment groups with multiple measurements obtained per 
replicate. All graphs show mean values plus or minus standard error of the means (S.E.M.) as well as 
individual values as dot plots. All bar graphs are overlaid with dot plots where each dot represents the 
value for one animal to show the distribution of data and the number (n) of animals per group. Files of all 
individual values are provided as source data. Injections of hydrogel formulations were repeated 
independently at least three times in different colonies of mice across a two-year period with similar 
results.  
 
Data availability statement 
Files of source data of individual values for all quantitative figures are provided with the paper. 
Other data that support the findings of this study are available on reasonable request from the 
corresponding author.    
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